Literature DB >> 11900052

A cellular model system of differentiated human myotubes.

M Gaster1, S R Kristensen, H Beck-Nielsen, H D Schrøder.   

Abstract

The aim of this study was to select an effective and stable protocol for the differentiation of human satellite cells (Sc) and to identify the optimal time period for the experimental use of differentiated human Sc-cultures. In order to identify the differentiation conditions which give a good survival of myotubes and a high grade of differentiation, Sc-cultures were induced to differentiate in media supplemented with either 2% fetal calf serum (FCS) 2% horse serum (HS) or 10% HS. Based on higher CK-activities in cultures differentiating in FCS-supplemented media compared to horse sera, fetal calf serum was chosen to induce differentiation. The ATP, DNA and protein content increased during the first 4 days after induction of differentiation and was followed by a period with minor changes. The maximal differences of ATP, DNA and protein between days 4-10 were evaluated and the differences in the three components were found to be less than 20% of the average value with a certainity of more than 0.9. Day 8-myotubes were investigated morphologically and were found immunoreactive for fast myosin, and expressed areas with clear cross striation. We recommend the use of differentiated Sc-cultures in the period from day 4 to 8 after induction of differentiation as only minor differentation-related changes will take place in the cells during this period of time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11900052     DOI: 10.1034/j.1600-0463.2001.d01-140.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  44 in total

1.  Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans.

Authors:  Stephan Sachs; Simona Zarini; Darcy E Kahn; Kathleen A Harrison; Leigh Perreault; Tzu Phang; Sean A Newsom; Allison Strauss; Anna Kerege; Jonathan A Schoen; Daniel H Bessesen; Thomas Schwarzmayr; Elisabeth Graf; Dominik Lutter; Jan Krumsiek; Susanna M Hofmann; Bryan C Bergman
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-01-08       Impact factor: 4.310

2.  Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes.

Authors:  Masaharu Iwasaki; Shuzo Urata; Yoshitake Cho; Nhi Ngo; Juan C de la Torre
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

3.  Uncoupling of sarcoplasmic reticulum Ca²⁺-ATPase by N-arachidonoyl dopamine. Members of the endocannabinoid family as thermogenic drugs.

Authors:  Y A Mahmmoud; M Gaster
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

4.  Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods.

Authors:  Tine E Thingholm; Steffen Bak; Henning Beck-Nielsen; Ole N Jensen; Michael Gaster
Journal:  Mol Cell Proteomics       Date:  2011-06-22       Impact factor: 5.911

5.  Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors.

Authors:  Adiba Isa; Jan O Nehlin; Hardee J Sabir; Tom E Andersen; Michael Gaster; Moustapha Kassem; Torben Barington
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

6.  Physical activity is associated with retained muscle metabolism in human myotubes challenged with palmitate.

Authors:  C J Green; T Bunprajun; B K Pedersen; C Scheele
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

7.  Liver X receptor antagonist reduces lipid formation and increases glucose metabolism in myotubes from lean, obese and type 2 diabetic individuals.

Authors:  E T Kase; G H Thoresen; S Westerlund; K Højlund; A C Rustan; M Gaster
Journal:  Diabetologia       Date:  2007-07-28       Impact factor: 10.122

8.  NDRG2, a novel regulator of myoblast proliferation, is regulated by anabolic and catabolic factors.

Authors:  Victoria C Foletta; Matthew J Prior; Nicole Stupka; Kate Carey; David H Segal; Sharon Jones; Courtney Swinton; Sheree Martin; David Cameron-Smith; Ken R Walder
Journal:  J Physiol       Date:  2009-02-09       Impact factor: 5.182

Review 9.  Design, evaluation, and application of engineered skeletal muscle.

Authors:  Mark Juhas; Jean Ye; Nenad Bursac
Journal:  Methods       Date:  2015-10-06       Impact factor: 3.608

10.  Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.

Authors:  C M Frederiksen; K Højlund; L Hansen; E J Oakeley; B Hemmings; B M Abdallah; K Brusgaard; H Beck-Nielsen; M Gaster
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.